ArticleClinical kidney journal2026

Subcutaneous ofatumumab for remission maintenance in pediatric idiopathic nephrotic syndrome: a case series.

Ning-Xun Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.